Background: Frequent and thorough monitoring of patient safety is a requirement of clinical trials research. Safety data are traditionally reported in a tabular or listing format, which often translates into many pages of static displays. This poses the risk that clinically relevant signals will be obscured by the sheer volume of data reported. Interactive graphics enable the delivery of the vast scope of information found in traditional reports, but allow the user to interact with the charts in real time, focusing on signals of interest. Methods: Clinical research staff, including biostatisticians, project managers, and a medical monitor, were consulted to guide the development of a set of interactive data visualizations that enable key safety assessments for participants. The resulting "Safety Explorer" is a set of 6 interactive, web-based, open source tools designed to address the shortcomings of traditional, static reports for safety monitoring. Results: The Safety Explorer is freely available on GitHub as individual JavaScript libraries: Adverse Event Explorer, Adverse Event Timelines, Safety Histogram, Safety Outlier Explorer, Safety Results Over Time, and Safety Shift Plot; or in a single combined framework: Safety Explorer Suite. The suite can also be utilized through its R interface, the safetyexploreR package. Conclusions: The Safety Explorer provides interactive charts that contain the same information available in standard displays, but the interactive interface allows for improved exploration of patterns and comparisons. Medical Monitors, Safety Review Boards, and Project Teams can use these tools to effectively track and analyze key safety variables and study endpoints.
Introduction
Data visualizations and statistical graphics have a wellestablished history in the conduct of clinical trials, but traditional methods are focused on static displays of data. In recent years, web-based interactive graphics have increased in popularity and usage, 1 including many innovative scientific data visualizations. [2] [3] [4] The clinical research industry seems poised to tap into this trend, as companies like SAS and Tableau now offer interactive online charting tools for clinical research and organizations such as PhUSE 5 and CTSPedia 6 encourage the application of innovative data visualization methods in clinical trials.
Statistical graphics are especially useful for safety oversight and risk-based monitoring. [7] [8] [9] The appeal of these tools for clinical investigators comes from the need to constantly monitor data and quickly identify concerns while trials are in progress. Interactive monitoring tools offer a promising alternative to traditional reporting approaches, which are characterized by the tedious review of pages of text-based listings. 7, 10 Such methods are not merely inefficient but also problematic, as the sheer volume of data reported threatens to obscure clinically relevant signals.
Interactive reports give researchers an intuitive and streamlined workflow for data analysis by combining a summary view of a given data domain with on-demand access to data listings for observations of special interest. 11 This approach can cover the broad scope of information found in traditional safety reports, while improving the signal-to-noise ratio and eliminating the need to sort through pages of static listings. Using these principles of interactive data visualization, we created the Safety Explorer, a set of open-source interactive graphics designed specifically for safety monitoring in clinical trials.
While other interactive data visualization tools for clinical research exist, they are generally packaged as add-ons to expensive clinical trial analytics environments and cannot be broadly shared or fully customized by the end-user (eg, JMP Clinical, SAS Analytics, Tableau CLINTEL). The Safety Explorer suite is open source and freely available, so it can be implemented in any contemporary web browser with no specialized or proprietary software required.
Methods
Six interactive graphics were developed for the Safety Explorer suite: Adverse Event Explorer, Adverse Event Timelines, Safety Histogram, Safety Outlier Explorer, Safety Results Over Time, and Safety Shift Plot. Clinical project staff-principal investigators, medical monitors, biostatisticians, project managers, and data managers-were consulted to provide use cases and design feedback on the charts. The charts were created to monitor key safety metrics at both the population-wide and participant-specific level. This dual utility is necessary for effective safety monitoring, which tasks monitors with protecting the well-being of individual participants as well as assessing product or intervention safety among all trial participants.
All graphics were built in JavaScript using d3.js 1 and the Webcharts framework. 12 No other dependencies are required, so the charts can be easily implemented in a variety of web environments and used in any modern web browser. The suite can also be utilized through its R interface with the safetyexploreR package, which implements the JavaScript libraries using the htmlwidgets framework. 13 The resulting interactive graphics can be viewed in the RStudio viewer, 14 embedded in an R Markdown document 15 or Shiny application, 16 or output as a standalone webpage. To encourage broad adoption of the tools, the data specifications were configured to match existing standards for common safety data domains. The charts use Clinical Data Interchange Standards Consortium's (CDISC's) Analysis Data Model (ADaM) standard, 17 which is the preferred, and soon to be mandated, standard for clinical data submission to the FDA. 18 Since trials increasingly conform to CDISC standards, the Safety Explorer can be used on a broad set of studies with very little configuration required. However, while the Safety Explorer is designed around the ADaM standard, it is also designed to be adaptable; the charts can easily be configured to use other data conventions via simple run-time data mapping.
Results
The Safety Explorer suite consists of 6 custom interactive graphics and 2 helper libraries ( Table 1 ). The 6 graphics libraries improve upon traditional static reports by adding simple user interface elements, including filters, dynamic searches, toggles for display options, and linked charts and listings. For example, the Adverse Event (AE) Explorer graphic provides group-level adverse event rates (Figure 1 ) while also allowing users to dynamically investigate adverse events data at a participant level (Figure 2 ). The adverse events table mirrors a familiar static AE summary 19, 20 when first initiated, showing AE rates categorized by system organ class and preferred term. Enhancements to the traditional report give the user the ability to drill down and examine details for comparisons of special interest. Interactive features include customizable filters and search capability, as well as the ability to select any row in order to display a detailed listing of the underlying raw data.
A second chart, the Safety Outlier Explorer, displays clinical results over time, allowing users to easily identify values that fall outside of expected ranges (Figure 3 ). An interactive control is provided to quickly display any measure of interest. Each line in the graph represents a single participant's results over the course of the study. Selecting an individual line generates a brief demographic overview of the participant along with a set of small charts showing the participant's results for all available measures and time points.
The 4 remaining charts consist of an AE timeline that provides a detailed participant-level view of AE activity and 3 additional views of key safety markers (ie, Lab Results and Vital Signs). Fully functional examples are publicly available online (Table 1) . The charts can be implemented individually or as a group using the safety-explorer-suite helper package or the safetyexploreR R package. In summary, the suite provides robust reporting capabilities for a typical longitudinal randomized clinical trial.
Discussion
Regardless of study phase or disease area, safety monitoring occurs during all stages of a clinical trial and must incorporate the principals of risk-based monitoring. 21 For large or complex trials, study monitors are charged with reviewing thousands of records, which are traditionally presented as many pages of tables or listings. Reporting this volume of data in text-based format across many different pages makes identifying clinically relevant signals difficult and time consuming. As such, the Safety Explorer is designed to be implemented at the beginning of a project and then used throughout the data pipeline. 22 The simple design of the tools allows for frequent or real-time data updates across a variety of environments with minimal overhead, and its interactivity provides a powerful platform for exploratory data analysis with no specialized training required. Further, the safetyexploreR package enables R users to initiate the charts with a single line of R code, allowing analysts to use the tools as part of their standard workflow for data cleaning and data exploration. (Figure 1 ) and access this detailed event-level view for the corresponding adverse events. This allows users to instantly toggle between summary data and participant-level data.
Improving access to safety data and creating a streamlined workflow is a key step toward a robust risk-based monitoring plan, but like any change to the traditional clinical trial workflow, it also creates new challenges. As with any standardized reporting tool, the Safety Explorer works best when the underlying data sets are stable, which can be a challenge early in clinical trials when analysis data sets may not be ready for use and case report form changes are more common. Further, the validation and regulatory framework differs for static statistical listings (typically, double programming) to interactive software (21 CFR Part 11). 23 Two key areas for further technical development of these tools are performance improvements for very large data sets, and incorporating more options for statistical testing. By running the current version of the Safety Explorer entirely through the web browser, performance is determined by the end user's computing environment and options for statistical testing are limited. Both of these constraints could be mitigated by supporting server-side processing and statistical calculations; however, these efforts should be balanced against the need to maintain the generalizability and ease of use of the tools.
Following an open source development paradigm distinguishes the Safety Explorer from many comparable data visualization tools, which are proprietary and require the purchase of a license. Not only is Safety Explorer freely available, the source code is public and available for users to customize and enhance. We anticipate that clinical research software will increasingly move toward open source tools, driven by the ideals of transparency, public good, and open sharing, which are prevalent among the scientific and web development communities. Clinical trial research groups such as PhUSE and CTSPedia primarily focus on tools built using traditional statistical programming languages, but are open to other types of applications, and may serve as important forums for interactive, open source tools as they become more common. In the future, open software platforms like Apple Figure 3 . Outlier Explorer. This chart presents data for individual participants for a given measure across the various collection points in a trial (eg, repeated lab tests). Each line in the chart represents a unique participant, allowing users to track changes over time and survey populationlevel trends. Selecting an individual participant's line toggles on a view of the other measures for that participant, providing a quick summary snapshot of all an individual's measures at one time. The "small multiple" charts of other measures also include shaded normal ranges to help the user see when values fall outside of the expected limits. Controls above the chart allow the user to change which measure is displayed and to change which values are displayed on the x-axis (eg, study day vs visit number.)
Health Kit and Open mHealth 24 may improve the accessibility of data visualization tools for clinical trials operations and safety monitoring. However, given the current lack of open source options in the clinical trials domain, the Safety Explorer suite fills a void in this area.
Conclusions
We have used the Safety Explorer to support several clinical trials, and it has proven to be a valuable tool. Our web-based implementation makes deployment and use of the tools simple. In addition, we ensure transparency, customizability, and reproducibility by developing, documenting and updating the tools in a fully open manner and releasing them under the permissive MIT license. Full technical specifications, data guidelines, user requirements, and more examples for all are available on the project's home page (https://rhoinc.github.io/safety-explorer-suite/) and all code is hosted on GitHub (https://github.com/RhoInc).
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